Rare Diseases
Latest News
Scientists discover variants, therapy for disabling pansclerotic morphea
The JAK inhibitor ruxolitinib dramatically improved wound healing and rashes in patients with the very rare disorder.
News from the FDA/CDC
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
News from the FDA/CDC
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
Conference Coverage
Low disease state for childhood lupus approaches validation
A new childhood version of the Lupus Low Disease Activity State has been purposefully developed to align with the criteria already used for adults...
ID Consult
New outbreaks of Marburg virus disease: What clinicians need to know
Overall, the risk of MVD in nonendemic countries, like the United States, is low but there is still a risk of importation.
Latest News
Study compares noninvasive treatments of cutaneous neurofibromas
The epidermis overlying cNF is normal, “so there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when...
Conference Coverage
Answers sought for mental health challenges in pediatric rheumatology patients
One study found a tremendous increase in screening by automating the process while another found remote delivery of a 6-week cognitive-behavioral...
Conference Coverage
Pretransfer visits with pediatric and adult rheumatologists smooth adolescent transition
The time from the last pediatric visit to the first adult visit was substantially shorter for patients who had a dual provider pretransfer visit...
Conference Coverage
Childhood lupus severity linked to social determinants of health
Social determinants of health were linked to lupus disease severity in children, but it will take more than awareness among doctors to address the...
Conference Coverage
Little change in rheumatology faculty coverage in pediatric residency programs in nearly 20 years
There has been little improvement in addressing the shortage of pediatric rheumatologists over the past 2 decades, boding poorly for future...
Feature
Biosimilars and patients: Discussions should address safety, cost, and anxiety about change
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and...